Changing epidemiology of infections due to extended spectrum beta-lactamase producing bacteria

Antimicrobial Resistance and Infection Control

Volumn 3, Issue 1, 2014, Pages

  Kassakian, Steven Z ^a   Mermel, Leonard A ^a,b  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

Antimicrobial resistance; Ciprofloxacin; Community acquired infections; Extended spectrum beta lactamase; Urinary tract infection

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; NITROFURANTOIN;

ABDOMINAL INFECTION; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BLOODSTREAM INFECTION; COHORT ANALYSIS; COMMUNICABLE DISEASE; DISEASE ASSOCIATION; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL INFECTION; HUMAN; INCIDENCE; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEUS; RETROSPECTIVE STUDY; SKIN INFECTION; SOFT TISSUE INFECTION; TERTIARY CARE CENTER; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION;

EID: 84907470564     PISSN: None     EISSN: 20472994     Source Type: Journal    
DOI: 10.1186/2047-2994-3-9     Document Type: Article

References (29)

1. Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993, 119(5):353-358. 10.7326/0003-4819-119-5-199309010-00001, 8135915.
2. Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, Bonomo RA, Rice LB, Wagener MM, McCormack JG, Yu VL. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections. Ann Intern Med 2004, 140(1):26-32. 10.7326/0003-4819-140-1-200401060-00008, 14706969.
3. Alcantar-Curiel D, Tinoco JC, Gavosso C, Carlos A, Daza C, Perez-Prado MC, Salcido L, Santos JI, Alpuche-Aranda CM. Nosocomial bacteremia and urinary tract infections caused by extended-spectrum beta -lactamase-producing Klebsiella pneumoniae with plasmids carrying both SHV-5 and TLA-1 genes. Clin Infect Dis 2004, 38(8):1067-1074. 10.1086/382354, 15095209.
4. Trick WE, Weinstein RA, DeMarais PL, Kuehnert MJ, Tomaska W, Nathan C, Rice TW, McAllister SK, Carson LA, Jarvis WR. Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J Am Geriatr Soc 2001, 49(3):270-276. 10.1046/j.1532-5415.2001.4930270.x, 11300237.
5. Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, Weinstein RA. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999, 281(6):517-523. 10.1001/jama.281.6.517, 10022107.
6. Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005, 56(1):52-59. 10.1093/jac/dki166, 15917288.
7. Ben-Ami R, Rodriguez-Bano J, Arslan H, Pitout JD, Quentin C, Calbo ES, Azap OK, Arpin C, Pascual A, Livermore DM, Garau J, Carmeli Y. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 2009, 49(5):682-690. 10.1086/604713, 19622043.
8. Smet A, Martel A, Persoons D, Dewulf J, Heyndrickx M, Herman L, Haesebrouck F, Butaye P. Broad-spectrum beta-lactamases among Enterobacteriaceae of animal origin: molecular aspects, mobility and impact on public health. FEMS Microbiol Rev 2010, 34(3):295-316. 10.1111/j.1574-6976.2009.00198.x, 20030731.
9. Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, Leavitt A, Carmeli Y. Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital. Clin Infect Dis 2006, 42(7):925-934. 10.1086/500936, 16511754.
10. Rodriguez-Bano J, Navarro MD, Romero L, Muniain MA, deCueto M, Rios MJ, Hernandez JR, Pascual A. Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin Infect Dis 2006, 43(11):1407-1414. 10.1086/508877, 17083012.
11. Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8(3):159-166. 10.1016/S1473-3099(08)70041-0, 18291338.
12. Institute, C.a.L.S Performance Standards for Antimicrobial Susceptibility Testing 2008, Wayne, PA: Clinical and Laboratory Standards Institute, Institute, C.a.L.S.
13. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16(3):128-140. 10.1016/0196-6553(88)90053-3, 2841893.
14. Prevention, C.f.D.C.a CDC/NHSN Surveillance Definition of Healthcare-Associated Infection and Criteria for Specific Types of Infections in the Acute Care Setting 2013, Available from: http://www.cdc.gov/nhsn/pdfs/pscmanual/17pscnosinfdef_current.pdf, Prevention, C.f.D.C.a.
15. Doi Y, Park YS, Rivera JI, Adams-Haduch JM, Hingwe A, Sordillo EM, Lewis JS, Howard WJ, Johnson LE, Polsky B, Jorgensen JH, Richter SS, Shutt KA, Paterson DL. Community-associated extended-spectrum beta-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis 2013, 56(5):641-648. 10.1093/cid/cis942, 3563390, 23150211.
16. Meier S, Weber R, Zbinden R, Ruef C, Hasse B. Extended-spectrum beta-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. Infection 2011, 39(4):333-340. 10.1007/s15010-011-0132-6, 21706226.
17. Tschudin-Sutter S, Frei R, Dangel M, Stranden A, Widmer AF. Rate of transmission of extended-spectrum Beta-lactamase-producing enterobacteriaceae without contact isolation. Clin Infect Dis 2012, 55(11):1505-1511. 10.1093/cid/cis770, 22955436.
18. Lewis JS, Herrera M, Wickes B, Patterson JE, Jorgensen JH. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob Agents Chemother 2007, 51(11):4015-4021. 10.1128/AAC.00576-07, 2151438, 17724160.
19. Pitout JD, Church DL, Gregson DB, Chow BL, McCracken M, Mulvey MR, Laupland KB. Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates. Antimicrob Agents Chemother 2007, 51(4):1281-1286. 10.1128/AAC.01377-06, 1855502, 17283198.
20. Bonkat G, Müller G, Braissant O, Frei R, Tschudin-Suter S, Rieken M, Wyler S, Gasser TC, Bachmann A, Widmer AF. Increasing prevalence of ciprofloxacin resistance in extended-spectrum-b-lactamase-producing Escherichia coli urinary isolates. World J Urol 2013, 31(6):1427-1432. 10.1007/s00345-013-1031-5, 23358791.
21. Tinelli M, Cataldo MA, Mantengoli E, Cadeddu C, Cunietti E, Luzzaro F, Rossolini GM, Tacconelli E. Epidemiology and genetic characteristics of extended-spectrum beta-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities. J Antimicrob Chemother 2012, 67(12):2982-2987. 10.1093/jac/dks300, 22865381.
22. 2011 Rhode Island Hospital Clinical Microbiology Laboratory Antimicrobial Statistics Data [cited 2012 28 November 2012]; Available from: http://intra.lifespan.org/rih/microbiology/documents/2011RIHInpt.pdf.
23. Johnson JR, Urban C, Weissman SJ, Jorgensen JH, Lewis JS, Hansen G, Edelstein PH, Robicsek A, Cleary T, Adachi J, Paterson D, Quinn J, Hanson ND, Johnston BD, Clabots C, Kuskowski MA, AMERECUS Investigators Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-beta-lactamase-producing E. coli from the United States, 2000 to 2009. Antimicrob Agents Chemother 2012, 56(5):2364-2370. 10.1128/AAC.05824-11, 3346636, 22354301, AMERECUS Investigators.
24. Leverstein-van Hall MA, Dierikx CM, Cohen Stuart J, Voets GM, van den Munckhof MP, van Essen-Zandbergen A, Platteel T, Fluit AC, van de Sande-Bruinsma N, Scharinga J, Bonten MJ, Mevius DJ, National ESBL surveillance group Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clin Microbiol Infect 2011, 17(6):873-880. 10.1111/j.1469-0691.2011.03497.x, 21463397, National ESBL surveillance group.
25. Kluytmans JA, Overdevest IT, Willemsen I, Kluytmans-van den Bergh MF, van der Zwaluw K, Heck M, Rijnsburger M, Vandenbroucke-Grauls CM, Savelkoul PH, Johnston BD, Gordon D, Johnson JR. Extended-spectrum beta-lactamase-producing Escherichia coli from retail chicken meat and humans: comparison of strains, plasmids, resistance genes, and virulence factors. Clin Infect Dis 2013, 56(4):478-487. 10.1093/cid/cis929, 23243181.
26. O'Keefe A, Hutton TA, Schifferli DM, Rankin SC. First detection of CTX-M and SHV extended-spectrum beta-lactamases in Escherichia coli urinary tract isolates from dogs and cats in the United States. Antimicrob Agents Chemother 2010, 54(8):3489-3492. 10.1128/AAC.01701-09, 2916344, 20479196.
27. Guenther S, Ewers C, Wieler LH. Extended-spectrum beta-lactamases producing E. coli in wildlife, yet another form of environmental pollution?. Front Microbiol 2011, 2:1-13. 3109420, 21716958.
28. Espinar MJ, Rocha R, Ribeiro M, Goncalves Rodrigues A, Pina-Vaz C. Extended-spectrum beta-lactamases of Escherichia coli and Klebsiella pneumoniae screened by the VITEK 2 system. J Med Microbiol 2011, 60(Pt 6):756-760.
29. Hombach M, Mouttet B, Bloemberg GV. Consequences of revised CLSI and EUCAST guidelines for antibiotic susceptibility patterns of ESBL- and AmpC beta-lactamase-producing clinical Enterobacteriaceae isolates. J Antimicrob Chemother 2013, 68(9):2092-2098. 10.1093/jac/dkt136, 23633681.